Open your free All-in-One trading account with zero hassle!
Nippon India Pharma Fund
Sectoral-PharmaRank #26
3/5
NAV (2026-09-11)
₹567.34
AUM
₹9,479.08 Cr
Exp. Ratio: 1.84%
RISK LEVEL
Very High
Returns & Performance
1 Year9.73%5.40% vs cat avgRank #24
3 Year17.50%3.23% vs cat avgRank #16
5 Year12.61%1.33% vs cat avgRank #10
Since Launch19.87%2.74% vs cat avg
Fund vs Category Average
1Y
9.73%-5.40%
3Y
17.50%-3.23%
5Y
12.61%-1.33%
Pros & Cons
Pros
✔No lock-in period
✔Outperforms category avg since launch
Cons
✖1Y returns trail category average
✖3Y returns below category average
✖5Y returns below category average
✖Higher expense ratio (1.84%)
✖1Y category rank outside top 15 (#24)
✖Overall rank #26 in category
ISININF204K01968
NAV₹567.34
NAV Date2026-09-11
AUM₹9,479.08 Cr
Expense Ratio1.84%
RiskVery High
Rating3 / 5
Min SIP Amount₹100
Max SIP Amount₹999999999
Min Additional Inv.₹1000
SIP AllowedYes
Plan TypeRegular
Plan OptionGrowth
Is NFONo
Fund House Incorp.1995-06-30
INVESTMENT OBJECTIVE
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
Exit Load1.00%
Stamp duty on investment0.005% (from July 1st, 2020)
Tax implicationsIf you redeem within one year, your returns will be taxed at 20%. For redemptions after one year, returns exceeding ₹1.25 lakh in a financial year will be taxed at 12.5%.
Amber Singhania
MMS Finance (Mumbai University)
Prior to joining the Nippon India AMC, he was associated with Asian Markets Securities Pvt. Ltd.
Common questions about this fund, answered from scheme data
The latest Net Asset Value (NAV) of Nippon India Pharma Fund is ₹567.34 as of 2026-09-11.
Nippon India Pharma Fund is classified as a Sectoral-Pharma fund.
Nippon India Pharma Fund is managed by Nippon India Mutual Fund.
The Assets Under Management (AUM) of Nippon India Pharma Fund is ₹9,479.08 Cr.
The expense ratio of Nippon India Pharma Fund is 1.84%.
Nippon India Pharma Fund is managed by Amber Singhania.
The minimum SIP investment for Nippon India Pharma Fund is ₹100.
The exit load for Nippon India Pharma Fund is 1%.
As per the SEBI Riskometer, Nippon India Pharma Fund carries a Very High risk level.
Nippon India Pharma Fund has delivered 9.73% (1Y), 17.5% (3Y) and 12.61% (5Y) annualised returns as of 2026-09-11.
Nippon India Pharma Fund was launched on 1995-06-30.
Open an account with Indiabulls Securities, complete your KYC, and invest via SIP or a one-time lumpsum through our platform.
A Systematic Investment Plan (SIP) lets you invest a fixed amount at regular intervals (e.g., monthly) instead of a single lumpsum.
There is no separate brokerage on mutual fund units. The AMC charges an expense ratio, which is already reflected in the NAV. An exit load may apply if you redeem before the specified period.
Mutual fund NAVs are declared once per business day after market close, in line with SEBI norms.
The FAQs above are generated from data provided by the AMC and are for educational purposes only. They do not constitute financial advice, buy/sell recommendations, or return guarantees. Mutual fund investments are subject to market risks — read all scheme-related documents carefully before investing. Past performance is not indicative of future returns.
